FDA Approved: BEYFORTUS — Supplemental Application (Sanofi Vaccines US Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Beyfortus (nirsevimab) submitted by Sanofi Vaccines US Inc. The document notes the submission status as AP (Appr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• BEYFORTUS (Nirsevimab)

Snippet

SUPPL AP for BEYFORTUS (NIRSEVIMAB)